To investigate the effects of asprosin on MASLD progression, we performed mRNA sequencing on liver samples from APOE(‐/‐) mice fed an HFHFHC diet, with and without hepatic asprosin overexpression. The gene discussed is FBN1; the disease is metabolic dysfunction-associated steatotic liver disease.